Disorders of Cardiac Rhythm

  • William G. Harmon


A fundamental understanding of cardiac electrophysiology allows the clinician to manipulate cardiac conduction in the clinical setting. The normal myocardium has the ability to generate, contract in response to, and propagate an action potential. Cardiac cells maintain an ion gradient with an overall negative intracellular charge. This transmembrane gradient allows for ion flow and the generation of the action potential, which is driving force for cardiac activity (Fig. 29-1). Cardiac cells maintain high intracellular potassium (140 mM) and low intracellular sodium (10 mM) concentrations as the major source of the transmembrane gradient. Low intra-cytoplasmic calcium levels (10−4 mM) also contribute to the resting equilibrium potential. These values have clinical implications, For example, a rise of the extracellular potassium concentration (hyperkalemia) decreases the cardiac transmembrane potential that, if severe, can ultimately lead to asystole. Conversely, bolus intravenous calcium administration augments the calcium component of the transmembrane gradient, and counteracts some of the negative electrophysiologic effects of hyperkalemia.


Atrial Flutter Accessory Pathway Ventricular Ectopy Reentrant Tachycardia Junctional Ectopic Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings

  1. Aguilera PA, Durham BA, Riley DA. Emergency transvenous cardiac pacing placement using ultrasound guidance. Ann Emerg Med. 2000;36:224–7.PubMedCrossRefGoogle Scholar
  2. Birkham RH, Gaeta TJ, Tloczkowski J, et al. Emergency medicine-trained physicians are proficient in the insertion of transvenous pacemakers. Ann Emerg Med. 2004;43:469–74.CrossRefGoogle Scholar
  3. Bromberg BI, Linday BD, Cain ME, et al. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1996;27:690–5.PubMedCrossRefGoogle Scholar
  4. Case CL. Radiofrequency catheter ablation of arrhythmias in infants and small children. Prog Pediatr Cardiol. 2000;11:77–82.PubMedCrossRefGoogle Scholar
  5. Cruz FE, Cheriex EC, Smeets JL, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16:739–44.PubMedCrossRefGoogle Scholar
  6. Da Costa A, Kirkorian G, Cucherate M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796–801.PubMedGoogle Scholar
  7. Fastle RK, Roback MG. Pediatric rapid sequence intubation: incidence of reflex bradycardia and effects of pretreatment with atropine. Pediatr Emerg Care. 2004;20:651–5.PubMedCrossRefGoogle Scholar
  8. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation. 2002;106:2145–61.PubMedCrossRefGoogle Scholar
  9. Haas NA, Kulasekaran K, Camphausen C. Beneficial hemodynamic response of transthoracic cardiac pacing in a 2 kg preterm neonate. Intensive Care Med. 2005;31(6):877–9.PubMedCrossRefGoogle Scholar
  10. Hoshino K, Ogawa K, Hishitani T, et al. Successful use of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int. 2006;48(2):112–7.PubMedCrossRefGoogle Scholar
  11. Maginot KR, Mathewson JW, Bichell DP, Perry JC. Applications of pacing strategies in neonates and infants. Prog Pediatr Cardiol. 2000;11(1):65–75.PubMedCrossRefGoogle Scholar
  12. Pinto N, Jones TK, Dyamenahalli U, Shah MJ. Temporary transvenous pacing with an active fixation bipolar lead in children: a preliminary report. Pacing Clin Electrophysiol. 2003;26(Pt I):1519–22.PubMedCrossRefGoogle Scholar
  13. Quan L, Graves JR, Diner DR, et al. Transcutaneous cardiac pacing in the treatment of out-of-hospital pediatric cardiac arrests. Ann Emerg Med. 1992;21:905–9.PubMedCrossRefGoogle Scholar
  14. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective β-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med. 2002;137:715–25.PubMedGoogle Scholar
  15. Van Hare FG, Javitz H, Carmellie D, et al. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles and initial outcomes. J Cardiovasc Electrophysiol. 2004;15: 759–70.PubMedCrossRefGoogle Scholar
  16. Vaughan WEM. Classifying antiarrhythmic actions: by facts or speculations. J Clin Pharmacol. 1992;32:964–77.Google Scholar
  17. Wen ZC, Chen SA, Ching TT, et al. Electrophysiologic mechanisms and determinants of Vagal Maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 1998;98:2716–23.PubMedGoogle Scholar
  18. Wennergren G, Bjure J, Hertzbert T, Lagercreanz H, Milerad J. Laryngeal reflex. Acta Paediatr Suppl. 1993;389:53–4.CrossRefGoogle Scholar


  1. Fogoros RN, editor. Practical cardiac diagnosis: electrophysiological testing. Cambridge: Blackwell Science, Inc; 1995.Google Scholar
  2. Hardman JG, Limbard LE, Goodman Gilman A, editors. Goodman and Gilman’s The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill Medical Publishing; 2001.Google Scholar
  3. Katz AM, editor. Physiology of the heart. 3rd ed. New York: Lippincott Williams & Wilkins; 2001.Google Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • William G. Harmon
    • 1
  1. 1.Pediatric Cardiology and Pediatric Critical Care Medicine, Department of PediatricsUniversity of Miami Miller School of Medicine, Holtz Children’s HospitalMiamiUSA

Personalised recommendations